A Study to Evaluate the Efficacy and Safety of MEDI0382 in the Treatment of Overweight and Obese Subjects With Type 2 Diabetes
Clinical trial NCT03235050 · COMPLETED
Trial details
- NCT number
- NCT03235050
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-02
- Primary completion
- 2018-05-03
- Enrollment
- 834
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.